Hi Kelsee, I definately think you are on to something, For the first time ever Dm has publicly announced in news articles to Bloomberg and others that RVX is being pursued to being purchased , The operative word being pursued, I think he is trying to let the market know without giving to giving away too much info. DM has mentioned in previous webcast in the past of potential buyout options with big pharma that would protect both parties to assure success. Thus I think we are looking at potential CVR staged /phased buyout with big pharma. The way I see it a big pharma could mAke initial buyout offer of around $500 to $700 million certified value right deal that would increase value upon meeting certain end points such as phase 3 success which would give shareholders more money the if there is FDA approval for RVX 208 then more $$ to current shareholder. Then we have the preffered royaltys that RVX shareholder would receive and potentially rollover to zenith shareholders Anyone else think this could happen in near future?